Mazindol

Chemical formula: C₁₆H₁₃ClN₂O  Molecular mass: 284.74 g/mol  PubChem compound: 4020

Active ingredient description

Mazindol is a sympathomimetic amine for the treatment of obesity and Duchenne muscular dystrophy. Like other sympathomimetic appetite suppressants, mazindol is thought to act as a reuptake inhibitor of norepinephrine. In addition, it inhibits dopamine and serotonin reuptake. It stimulates the central nervous system, which increases heart rate and blood pressure, and decreases appetite.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
A08AA05 Mazindol A Alimentary tract and metabolism → A08 Antiobesity preparations, excl. diet products → A08A Antiobesity preparations, excl. diet products → A08AA Centrally acting antiobesity products
Discover more medicines within A08AA05

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 22232-71-9
DrugBank Drug: DB00579
KEGG Drug: D00367
PubChem Compound: 4020
RxNorm Ingredient: 6664
SNOMED-CT Concept: 387232005
Mazindol (substance)
UNII Identifier: C56709M5NH
MAZINDOL

Medicines

Mazindol is an active ingredient of these brands:

Ecuador (EC)

Japan (JP)

Mexico (MX)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.